🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, claiming the corporations withheld alleged dangers that the pain reliever presented to pediatric neurological development.

The court filing follows thirty days after President Donald Trump publicized an unverified association between taking Tylenol - referred to as paracetamol - during pregnancy and autism spectrum disorder in offspring.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he said they "deceived the public by profiting off of pain and promoting medication ignoring the potential hazards."

The company says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These corporations deceived for years, deliberately risking countless individuals to increase profits," the attorney general, a Republican, declared.

The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its online platform, Kenvue also stated it had "consistently assessed the applicable studies and there is insufficient valid information that indicates a verified association between consuming acetaminophen and autism."

Associations acting on behalf of physicians and health professionals concur.

ACOG has declared acetaminophen - the key substance in Tylenol - is among limited choices for pregnant women to treat discomfort and elevated temperature, which can present serious health risks if left untreated.

"In multiple decades of research on the consumption of paracetamol in gestation, zero credible investigations has definitively established that the usage of paracetamol in any trimester of pregnancy causes neurodevelopmental disorders in offspring," the group stated.

The court filing references recent announcements from the previous government in asserting the drug is reportedly hazardous.

In recent weeks, the former president generated worry from medical authorities when he told pregnant women to "struggle intensely" not to use Tylenol when unwell.

Federal regulators then published an announcement that doctors should think about restricting the usage of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in April to undertake "comprehensive study program" that would determine the cause of autism in a short period.

But specialists advised that identifying a single cause of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a type of enduring cognitive variation and impairment that influences how persons encounter and interact with the world, and is identified using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the research" around paracetamol and autism.

The case attempts to require the corporations "eliminate any promotional materials" that claims acetaminophen is secure for pregnant women.

The court case parallels the grievances of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in recently.

Judicial authorities dismissed the lawsuit, stating studies from the plaintiffs' authorities was lacking definitive proof.